Dentsply Sirona Inc. (XRAY): Price and Financial Metrics

XRAY POWR Grades

• XRAY scores best on the Value dimension, with a Value rank ahead of 89.98% of US stocks.
• The strongest trend for XRAY is in Growth, which has been heading down over the past 160 days.
• XRAY's current lowest rank is in the Momentum metric (where it is better than 14.15% of US stocks).

XRAY Stock Summary

• DENTSPLY SIRONA Inc's market capitalization of $11,621,149,502 is ahead of 82.72% of US-listed equities.
• XRAY's went public 30.76 years ago, making it older than 83.42% of listed US stocks we're tracking.
• Over the past twelve months, XRAY has reported earnings growth of -10,837.5%, putting it ahead of merely 0.05% of US stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to DENTSPLY SIRONA Inc are VSTO, CLF, BYD, TALO, and ENSV.
• XRAY's SEC filings can be seen here. And to visit DENTSPLY SIRONA Inc's official web site, go to www.dentsplysirona.com.

XRAY Valuation Summary

• XRAY's EV/EBIT ratio is 29.3; this is 0% higher than that of the median Healthcare stock.
• XRAY's price/sales ratio has moved up 0.8 over the prior 243 months.
• Over the past 243 months, XRAY's price/sales ratio has gone up 0.8.

Below are key valuation metrics over time for XRAY.

XRAY Growth Metrics

The 3 year price growth rate now stands at -10.85%.
• The 2 year net cashflow from operations growth rate now stands at 3.19%.
• The 5 year revenue growth rate now stands at 41.81%.

Over the past 49 months, XRAY's revenue has gone up $346,400,000.

The table below shows XRAY's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	4,245.3	698.5	417.5
2021-06-30	4,071.1	733.6	368.3
2021-03-31	3,494.7	694.7	173.9
2020-12-31	3,342	635	-83
2020-09-30	3,371.2	670.8	-79.2
2020-06-30	3,438.5	622.8	-48

XRAY's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• XRAY has a Quality Grade of C, ranking ahead of 67.88% of graded US stocks.
• XRAY's asset turnover comes in at 0.443 -- ranking 108th of 186 Medical Equipment stocks.
• ZBH, PEN, and IVC are the stocks whose asset turnover ratios are most correlated with XRAY.

The table below shows XRAY's key quality metrics over time.